BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8806575)

  • 1. Interaction between the cytoplasmic domains of HIV-1 Vpu and CD4: role of Vpu residues involved in CD4 interaction and in vitro CD4 degradation.
    Margottin F; Benichou S; Durand H; Richard V; Liu LX; Gomas E; Benarous R
    Virology; 1996 Sep; 223(2):381-6. PubMed ID: 8806575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human immunodeficiency virus type 1 Vpu protein tethered to the CD4 extracellular domain is localized to the plasma membrane and is biologically active in the secretory pathway of mammalian cells: implications for the mechanisms of Vpu function.
    Raja NU; Jabbar MA
    Virology; 1996 Jun; 220(1):141-51. PubMed ID: 8659106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of heterologous protein degradation by the Vpu protein of HIV-1 requires the transmembrane and cytoplasmic domains of CD4.
    Buonocore L; Turi TG; Crise B; Rose JK
    Virology; 1994 Oct; 204(1):482-6. PubMed ID: 8091684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of CD4 induced by human immunodeficiency virus type 1 Vpu protein: a predicted alpha-helix structure in the proximal cytoplasmic region of CD4 contributes to Vpu sensitivity.
    Yao XJ; Friborg J; Checroune F; Gratton S; Boisvert F; Sékaly RP; Cohen EA
    Virology; 1995 Jun; 209(2):615-23. PubMed ID: 7778293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional analysis of the membrane-spanning domain of the human immunodeficiency virus type 1 Vpu protein.
    Tiganos E; Friborg J; Allain B; Daniel NG; Yao XJ; Cohen EA
    Virology; 1998 Nov; 251(1):96-107. PubMed ID: 9813206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vpu-mediated CD4 down-regulation and degradation is conserved among highly divergent SIV(cpz) strains.
    Gomez LM; Pacyniak E; Flick M; Hout DR; Gomez ML; Nerrienet E; Ayouba A; Santiago ML; Hahn BH; Stephens EB
    Virology; 2005 Apr; 335(1):46-60. PubMed ID: 15823605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of both phosphoacceptor sites in the HIV-1 Vpu cytoplasmic domain is essential for Vpu-mediated ER degradation of CD4.
    Paul M; Jabbar MA
    Virology; 1997 May; 232(1):207-16. PubMed ID: 9185604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif.
    Schubert U; Henklein P; Boldyreff B; Wingender E; Strebel K; Porstmann T
    J Mol Biol; 1994 Feb; 236(1):16-25. PubMed ID: 8107101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction by human immunodeficiency viruses types 1 and 2 of degradation of CD4 but not of a CD4 mutant unable to bind viral envelope glycoproteins.
    Cucchiarini M; Cagnon L; Giordanengo V; Doglio A; Lefebvre JC
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(5):427-36. PubMed ID: 7697438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR studies of the phosphorylation motif of the HIV-1 protein Vpu bound to the F-box protein beta-TrCP.
    Coadou G; Gharbi-Benarous J; Megy S; Bertho G; Evrard-Todeschi N; Segeral E; Benarous R; Girault JP
    Biochemistry; 2003 Dec; 42(50):14741-51. PubMed ID: 14674748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A molecular clone of simian-human immunodeficiency virus (DeltavpuSHIV(KU-1bMC33)) with a truncated, non-membrane-bound vpu results in rapid CD4(+) T cell loss and neuro-AIDS in pig-tailed macaques.
    McCormick-Davis C; Dalton SB; Hout DR; Singh DK; Berman NE; Yong C; Pinson DM; Foresman L; Stephens EB
    Virology; 2000 Jun; 272(1):112-26. PubMed ID: 10873754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine.
    Hout DR; Gomez LM; Pacyniak E; Miller JM; Hill MS; Stephens EB
    Virology; 2006 May; 348(2):449-61. PubMed ID: 16458946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substitution of the transmembrane domain of Vpu in simian-human immunodeficiency virus (SHIVKU1bMC33) with that of M2 of influenza A results in a virus that is sensitive to inhibitors of the M2 ion channel and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Gomez LM; Fegley B; Mulcahy ER; Hill MS; Culley N; Pinson DM; Nothnick W; Powers MF; Wong SW; Stephens EB
    Virology; 2006 Jan; 344(2):541-59. PubMed ID: 16199074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
    Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of the casein kinase II phosphorylation sites of Vpu enhances the CD4(+) T cell loss caused by the simian-human immunodeficiency virus SHIV(KU-lbMC33) in pig-tailed macaques.
    Singh DK; Griffin DM; Pacyniak E; Jackson M; Werle MJ; Wisdom B; Sun F; Hout DR; Pinson DM; Gunderson RS; Powers MF; Wong SW; Stephens EB
    Virology; 2003 Sep; 313(2):435-51. PubMed ID: 12954211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope mapping of the phosphorylation motif of the HIV-1 protein Vpu bound to the selective monoclonal antibody using TRNOESY and STD NMR spectroscopy.
    Gharbi-Benarous J; Bertho G; Evrard-Todeschi N; Coadou G; Megy S; Delaunay T; Benarous R; Girault JP
    Biochemistry; 2004 Nov; 43(46):14555-65. PubMed ID: 15544326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulated degradation of the HIV-1 Vpu protein through a betaTrCP-independent pathway limits the release of viral particles.
    Estrabaud E; Le Rouzic E; Lopez-Vergès S; Morel M; Belaïdouni N; Benarous R; Transy C; Berlioz-Torrent C; Margottin-Goguet F
    PLoS Pathog; 2007 Jul; 3(7):e104. PubMed ID: 17676996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein.
    Friborg J; Ladha A; Göttlinger H; Haseltine WA; Cohen EA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):10-22. PubMed ID: 8548340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of the hydrophilic C-terminal domain of the human immunodeficiency virus type 1-encoded virus protein U (Vpu).
    Henklein P; Schubert U; Kunert O; Klabunde S; Wray V; Klöppel KD; Kiess M; Portsmann T; Schomburg D
    Pept Res; 1993; 6(2):79-87. PubMed ID: 8387359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 particle release mediated by Vpu is distinct from that mediated by p6.
    Schwartz MD; Geraghty RJ; Panganiban AT
    Virology; 1996 Oct; 224(1):302-9. PubMed ID: 8862425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.